In this study, patients with PD-L1+ MEL survived significantly longer than patients with PD-L1− MEL, spurring investigators to hypothesize that TILs may actually prompt their own inhibition by secreting cytokines (such as IFN-γ) that drive tumor PD-L1 expression. The gene discussed is CD274; the disease is neoplasm.